Ultragenyx Pharmaceutical, Inc. (RARE)
23.71
+0.34
(+1.45%)
USD |
NASDAQ |
May 21, 16:00
23.70
-0.01
(-0.04%)
After-Hours: 19:59
Ultragenyx Pharmaceutical Accounts Payable (Quarterly) : 42.00M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 7.151M |
| BioMarin Pharmaceutical, Inc. | 395.47M |
| Regeneron Pharmaceuticals, Inc. | 1.027B |
| Xencor, Inc. | 7.919M |
| REGENXBIO, Inc. | 21.21M |